Magazine article Drug Topics

New Products

Magazine article Drug Topics

New Products

Article excerpt



New drugs

Genentech announced FDA approval of Actemra (tocflizumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). The first interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody approved to treat RA, Actemra may be used alone or in combination with methotrexate or other disease -modifying antirheumatic drugs. Visit www.actemra. com for more information, including boxed warnings and medication guide.

Sciele announced the availability of Adrenaclick (epinephrine injection autoinjector) for the emergency treatment of severe allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, and diagnostic testing substances, as well as anaphylaxis to unknown substances or exercise -induced anaphylaxis. Adrenaclick is available as a single-dose auto-injector in 0. 15 -mg and 0.3 -mg dosage strengths as a single unit or a two -pack. For more information visit or call 800-849-9707.

Elan and Acorda announced that FDA has approved Ampyra (dalfampridine) extended-release tablets to improve walking in adults with multiple sclerosis (MS). Ampyra closes the exposed potassium channels on demyelinated axons, which cause nerve impulse "short circuits," thus improving nerveimpulse conduction. For more information, visit or call 914-347-4300.

Fera has made available Bacitracin ophttiahnic orrtment, a sterile anti-infective ophthalmic agent available by prescription. Bacitracin ophthalmic ointment is indicated for the treatment of susceptible superficial ocular infections involving the conjunctiva and/or cornea. For more information, visit www.ferapharma. com or call 414-434-6604.

Fan apt (iloperidone) tablets are now available from Novartis. An atypical antipsychotic for the acute treatment of schizophrenia in adults, Fanapt is a mixed dopamine D2 /serotonin 5-HT2A receptor antagonist. Call 888-669-6682 or visit for more information.

Alaven has made available sfROWASA (mesalamine), a sulfite -free rectal suspension for the treatment of active mildto -moderate distal ulcerative colitis (UC), proctosigmoiditis, or proctitis. sfROWASA is available in a 4 g/60 mL dosage strength. Visit or call 888-317-0001 for more information. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed


An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.